Signs of Skin Cancer & Prevention
Steven Chen, MD, MPH discusses important signs of skin cancer to watch for and shares skin cancer prevention tips you need to stay safe in all four seasons.
Contact Information
New Patients
If you have not previously seen a doctor within the Mass General Brigham Network:
Step 1. Obtain a medical record number (MRN).
Call the Mass General Registration & Referral Center to register as a patient and obtain an MRN: 866-211-6588.
Step 2. Call the Cancer Center new patient appointment line: 617-726-5130.
The schedulers can assist you in making the first available appointment with the appropriate physician. To help your call go smoothly, please have ready your:
Existing Patients
Call the Center for Melanoma scheduling line: 617-724-5197. They will connect you with your treatment team.
The Center for Melanoma integrates the most current knowledge of cancer genetics, world-class resources for diagnosing and staging skin cancers, and leading-edge treatment approaches to provide personalized care and support services to adults, adolescents and children diagnosed with invasive or non-invasive melanoma.
This program is recognized worldwide for the evaluation and treatment of:
Our physicians and research scientists are recognized globally for developing new treatment approaches for melanoma and other skin cancers. These programs include:
Each patient in the melanoma program is cared for by a multidisciplinary team of experts who specialize in the diagnosis and treatment of skin cancers.
Depending on the type and stage of your cancer, your care team may include:
Members of your care team meet regularly with you and your referring physician to ensure good communication and coordination of care.
In this video, Genevieve Boland, MD, PhD, head of melanoma and sarcoma surgery, and surgical director of the Mass General Cancer Center Termeer Center for Targeted Therapies, shares how targeted treatments, immunotherapies and multidisciplinary collaboration have impacted melanoma care.
Our dermatologists see a large number of melanoma patients and are highly expert at recognizing suspect moles and other lesions. They are early adopters of techniques and technologies that improve diagnostics and are on the forefront of evaluation and monitoring of melanoma and other skin cancers. The diagnostic and staging information provided by these specialists helps define the best treatment for your disease.
In addition, our world-renowned pathologists are leading research projects to improve diagnoses of melanoma and skin cancers, identify which patients are more likely to develop metastatic disease, and to determine the effectiveness of therapy early in the treatment program.
Our surgeons offer the highest degree of clinical expertise available in the treatment of these cancers. Among the procedures offered here are:
We are one of only a few centers in the country offering proton beam radiation. This approach is being used here for ocular melanoma, providing pinpoint accuracy to help preserve the eye in many cases. Your care team may suggest radiation therapy to reduce the size of tumors that are causing discomfort or interfering with your body’s functioning, or as an adjuvant therapy following removal of lymph nodes containing melanoma. Our radiation technologists are skilled at standard and novel technologies, including intensity modulated radiation therapy (IMRT).
Melanoma research underway at the Cancer Center is aimed at uncovering cancer-causing gene mutations and drugs that can target them. Studies include examining the effectiveness of existing targeted drugs, identifying tumor biomarkers which may improve management of melanoma in any stage, and studying the molecular basis beneath the link between UV exposure and melanoma and using this information to devise new prevention strategies.
Through the process of tumor-infiltrating lymphocyte (TIL) therapy, a patient’s own TILs are reinvigorated to treat cancer. Mass General Cancer Center is one of the first centers to provide TIL therapy to patients with advanced melanoma.
Learn more about TIL Therapy for melanoma.
Clinical research is conducted at the Pigmented Lesion Clinic — a major center for melanoma patient care in the New England area and a leader in all aspects of melanoma investigation — and at the Cancer Center, which offers a wide array of experimental therapeutics for patients with advanced melanoma.
Find clinical trials for melanoma.
We help to identify families that may have a hereditary melanoma syndrome.
Learn about Mass General's Melanoma & Skin Cancer Surgery Program.
The nation's longest-standing clinic providing care for patients with cutaneous melanoma.
We offer a variety of education and support resources to help you and your family.
Mass General Cancer Center dermatologist Shawn Demehri, MD explains how to check for the early signs of melanoma and the importance of a multidisciplinary approach to treatment.
Go behind the scenes with our Director of Clinical Research, Dr. Keith Flaherty to learn how teams of researchers and clinicians are applying scientific insights to propel the creation of new therapies for patients, and get to know more about what motivates him to do what he does every day.
Support Melanoma Research
Your gift will help advance the development of leading edge, targeted treatments for melanoma, personalized for each patient. Make a gift.
Our support programs can help patients and their families cope with the challenges of a cancer diagnosis.
This helped lead to new knowledge and breakthrough therapies.
Steven Chen, MD, MPH discusses important signs of skin cancer to watch for and shares skin cancer prevention tips you need to stay safe in all four seasons.
A study led by researchers at Mass General Brigham has found that an individualized cancer therapy tailored to the unique tumor profiles of patients with melanoma and lung cancer was well-tolerated and boosted immune activity.
Steven Chen, MD, MPH discusses important signs of skin cancer to watch for and shares skin cancer prevention tips you need to stay safe in all four seasons.
A study led by researchers at Mass General Brigham has found that an individualized cancer therapy tailored to the unique tumor profiles of patients with melanoma and lung cancer was well-tolerated and boosted immune activity.
Steven Chen, MD, MPH discusses important signs of skin cancer to watch for and shares skin cancer prevention tips you need to stay safe in all four seasons.
A study led by researchers at Mass General Brigham has found that an individualized cancer therapy tailored to the unique tumor profiles of patients with melanoma and lung cancer was well-tolerated and boosted immune activity.
Contact the Mass General Cancer Center to make an appointment or to learn more about our programs.